Medical contact
Let’s connect to innovate in regenerative medicine.
Let’s connect to innovate in regenerative medicine.
Phone
56 62 29 23 51
Address
Lope de Vega 117, Polanco, Polanco V Secc, Miguel Hidalgo, 11560 Ciudad de México, CDMX
Write to us
From palliation to regenerative medicine.
For decades, the management of joint pathologies has focused primarily on pain control and the symptomatic suppression of inflammation. However, advances in biotechnology and regenerative medicine have made it possible to better understand the biological processes involved in cartilage degeneration, opening new therapeutic possibilities aimed at addressing the condition from its tissue origin.
Today, intra-articular cellular therapies and chondral implants allow specialists to intervene directly in the repair processes of musculoskeletal tissue. At Gencell Trauma & Orthopedics, we develop biotechnological solutions designed to support the regeneration of articular cartilage and expand the physician’s therapeutic options in the treatment of chondral lesions and degenerative joint pathologies.
Allows the specialist to repair focal chondral defects through the implantation of matrices with autologous chondrocytes, promoting the regeneration of articular cartilage and helping restore the functional surface of the joint in patients with advanced lesions.
Allows the application of intra-articular cellular therapy to modulate joint inflammation and support regenerative processes in patients with osteoarthritis, chondromalacia, or chondral damage, expanding therapeutic options within conservative orthopedic management.
Integrate cellular therapies and tissue engineering solutions into your orthopedic practice to treat complex joint pathologies, improve the patient’s functional recovery, and expand your therapeutic approach in regenerative medicine.
Clinical applications in regenerative orthopedics.
Discover how Gencell biotechnological solutions can be integrated into modern orthopedic practice to address joint injuries, improve the patient’s functional recovery, and expand the therapeutic options available to the specialist.
Chondral repair with biological implants
Allows the repair of focal chondral defects through biological implants that promote the regeneration of articular cartilage.
- Treatment of grade III–IV chondral defects.
- Structural restoration of articular cartilage.
Cellular therapy for joint pathologies
Allows the application of intra-articular cellular therapy to modulate inflammation and support regeneration in degenerative joint pathologies.
- Biological management of early osteoarthritis.
- Biological management of early osteoarthritis.
Regenerative solutions for orthopedic specialists
Advanced biological therapies designed to support cartilage repair and joint regeneration.
Professional access
Access to regenerative solutions designed for specialists who integrate advanced biological therapies.
Chondro Matrix
- Technology for the repair of focal chondral defects.
- Support for regenerative orthopedic procedures.
- Designed for integration into surgical practice.
- Promotes structural regeneration of articular cartilage.
CTM Metformin IA
- Intra-articular therapy for joint regeneration.
- Helps modulate inflammatory joint processes.
- Minimally invasive application in clinical practice.
- Promotes recovery of joint tissue.
All specialists receive:
- Personalized scientific guidance.
- Implementation support.
- Access to medical documentation.
- Technical and medical support.
Frequently asked questions.
Quick answers about our regenerative solutions and their integration into medical practice.
What type of physicians can use these treatments?
The solutions are designed for traumatologists, orthopedic specialists, and physicians focused on regenerative joint medicine.
Do the products require specialized training?
Yes. We provide training and clinical guidance to ensure proper therapeutic implementation.
Can these treatments be easily integrated into my practice?
Yes. They are designed to be integrated into surgical procedures or intra-articular therapies within medical practice.
What scientific evidence supports these therapies?
The products are developed under biomedical research and are supported by scientific foundations in regenerative medicine.
What clinical outcomes can be expected?
The treatments aim to reduce inflammation, improve joint function, and support cartilage regeneration.
Do you offer medical support or clinical guidance?
Yes. Our team provides scientific guidance, clinical follow-up, and support during implementation.
Our medical team can provide scientific information, clinical guidance, and orientation about the available treatments.